FDA Moves To Improve In Wake Of Safety Scrutiny
Congress has introduced several bills that would change regulations regarding drug safety despite moves the U.S. Food and Drug Administration has already made in the wake of the withdrawal of Vioxx...To view the full article, register now.
Already a subscriber? Click here to view full article